Trials / Sponsors / Polish Myeloma Consortium
Polish Myeloma Consortium
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Pre-emptive Daratumumab Therapy of Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple My Multiple Myeloma | Phase 2 | 2018-12-10 |
| Unknown | A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobuline Waldenstrom Macroglobulinemia | Phase 2 | 2018-09-21 |